A COLLABORATIVE
APPROACH TO IBD.
We are committed to fighting inflammatory diseases like IBD. But we’re not alone. We problem-solve across our global offices in 35 countries. We collaborate with external partners to develop innovative therapeutic approaches and aim to further advance the care of patients.